We are live on ! Find out more
ACA

Apis Capital Advisors Portfolio holdings

AUM $648M
1-Year Est. Return 302.67%
This Fund
S&P 500
This Quarter Est. Return
+32.84%
1 Year Est. Return
+302.67%
3 Year Est. Return
+1,035.2%
5 Year Est. Return
+2,376.05%
10 Year Est. Return
–
AUM
$82.9M
AUM Growth
+$8.31M
Cap. Flow
-$9.13M
Cap. Flow %
-11.01%
Top 10 Hldgs %
75.35%
Holding
34
New
8
Increased
4
Reduced
18
Closed
3

Top Buys

Rank Stock Value
1
KEM
KEMET Corporation
KEM
+$2.39M
2
AERI
Aerie Pharmaceuticals
AERI
+$1.32M
3
DERM
Dermira, Inc.
DERM
+$750K
4
VICR icon
Vicor
VICR
+$738K
5
CCRD
CoreCard
CCRD
+$436K

Top Sells

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$3.33M
2
NVCR icon
NovoCure
NVCR
+$2.68M
3
I
INTELSAT S. A.
I
+$2.12M
4
SIMO icon
Silicon Motion
SIMO
+$2.03M
5
GLNG icon
Golar LNG
GLNG
+$1.54M

Sector Composition

Rank Sector Weight
1 Healthcare 58.13%
2 Technology 9.62%
3 Consumer Discretionary 6.96%
4 Energy 6.21%
5 Industrials 2.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRN
1
Amarin Corp
AMRN
$299M
$23.4M 28.21%
56,335
-1,765
-3% -$637K
ARRY
2
DELISTED
Array Biopharma Inc
ARRY
$8.04M 9.7%
330,000
-160,000
-33% -$3.33M
ZGNX
3
DELISTED
Zogenix, Inc.
ZGNX
$6.79M 8.19%
123,500
-30,000
-20% -$1.43M
KEM
4
DELISTED
KEMET Corporation
KEM
$5.77M 6.96%
340,000
+130,000
+62% +$2.39M
GLNG icon
5
Golar LNG
GLNG
$5B
$5.15M 6.21%
244,000
-70,000
-22% -$1.54M
VICR icon
6
Vicor
VICR
$9.56B
$3.72M 4.49%
120,000
+20,000
+20% +$738K
CYBE
7
DELISTED
Cyberoptics Corp
CYBE
$3.07M 3.7%
179,461
-40,539
-18% -$804K
BSTC
8
DELISTED
BioSpecifics Technologies Corp.
BSTC
$2.24M 2.71%
36,000
-4,000
-10% -$265K
I
9
CALL
DELISTED
INTELSAT S. A.
I
$2.19M 2.64%
+140,000
New +$2.97M
SIMO icon
10
Silicon Motion
SIMO
$8.6B
$2.1M 2.53%
52,900
-52,100
-50% -$2.03M
GDOT icon
11
Green Dot
GDOT
$743M
$1.94M 2.34%
32,000
-8,000
-20% -$558K
VKTX icon
12
Viking Therapeutics
VKTX
$3.7B
$1.49M 1.8%
150,000
+30,000
+25% +$251K
CBAY
13
DELISTED
Cymabay Therapeutics
CBAY
$1.46M 1.76%
110,000
-50,000
-31% -$532K
VRSK icon
14
Verisk Analytics
VRSK
$25.4B
$1.43M 1.72%
10,750
-1,250
-10% -$152K
AERI
15
DELISTED
Aerie Pharmaceuticals
AERI
$1.43M 1.72%
+30,000
New +$1.32M
MTCH icon
16
Match Group
MTCH
$9.19B
$1.42M 1.71%
25,000
-10,000
-29% -$529K
GBT
17
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.32M 1.6%
25,000
-2,000
-7% -$98.3K
NVCR icon
18
NovoCure
NVCR
$1.73B
$1.22M 1.48%
25,400
-55,700
-69% -$2.68M
DERM
19
DELISTED
Dermira, Inc.
DERM
$1.22M 1.47%
+90,000
New +$750K
SRPT icon
20
Sarepta Therapeutics
SRPT
$1.57B
$1.19M 1.44%
10,000
-2,000
-17% -$257K
I
21
DELISTED
INTELSAT S. A.
I
$1.1M 1.32%
70,000
-100,000
-59% -$2.12M
LIQT icon
22
LiqTech
LIQT
$23M
$989K 1.19%
14,375
+437
+3% +$27.9K
DSPG
23
DELISTED
DSP Group Inc
DSPG
$982K 1.18%
69,800
-30,200
-30% -$393K
AMR icon
24
Alpha Metallurgical Resources
AMR
$1.74B
$927K 1.12%
16,000
– –
CCRD
25
DELISTED
CoreCard
CCRD
$639K 0.77%
+20,000
New +$436K
1
2

Similar funds

TWP
Tyche Wealth Partners Plano, Texas $648M AUM 20.17% 1-Year Est. Return
CAAM
Cornerstone Advisors Asset Management Bethlehem, Pennsylvania $648M AUM 11.43% 1-Year Est. Return
GAMA
Graticule Asia Macro Advisors New York $649M AUM
RK
Rather & Kittrell Knoxville, Tennessee $648M AUM 14.68% 1-Year Est. Return
PCM
Primavera Capital Management George Town, Cayman Islands $648M AUM 6.1% 1-Year Est. Return
ITC
Inspire Trust Company Reno, Nevada $648M AUM 19.45% 1-Year Est. Return
CCA
Carrera Capital Advisors Troy, Michigan $649M AUM 19.82% 1-Year Est. Return
SCM
Stevens Capital Management Radnor, Pennsylvania $649M AUM 27.37% 1-Year Est. Return

Apis Capital Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Apis Capital Advisors held 34 positions worth $82.9M, up 11% from $74.6M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Apis Capital Advisors withdrew a net $9.13M in Q1 2019, closing 3 positions and reducing 18 holdings. Its most notable exit was Electro Scientific Industries, an estimated $899K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Apis Capital Advisors opened a new position in Aerie Pharmaceuticals worth $1.43M.

  • Apis Capital Advisors's largest Q1 2019 buy was Aerie Pharmaceuticals: 30,000 shares worth $1.43M.
  • Apis Capital Advisors added most to KEMET Corporation in Q1 2019, an estimated $2.39M increase.
  • Apis Capital Advisors's biggest Q1 2019 reduction was Array Biopharma Inc, cutting an estimated $3.33M.
  • Apis Capital Advisors fully exited Electro Scientific Industries in Q1 2019, selling an estimated $899K.
  • Apis Capital Advisors's ten largest holdings make up 75% of its $82.9M portfolio in Q1 2019.
  • Apis Capital Advisors opened 8 new positions and closed 3 in Q1 2019.
  • Apis Capital Advisors's portfolio value rose 11% quarter-over-quarter to $82.9M.

Based on Apis Capital Advisors's 13F filing for Q1 2019, filed 7 May 2019.